Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
Keywords:
folliculitis decalvans, EGFR inhibitors, drug-induced alopecia, cancer patients, antibiotic therapyReferences
Kozuki T. Skin problems and EGFR-tyrosine kinase inhibitor. Jpn J Clin Oncol. 2016;46(4):291-298. DOI: 10.1093/jjco/hyv207. PMID: 26826719. PMCID: PMC4886131.
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al. Folliculitis decalvans: a multicentre review of 82 patients. J Eur Acad Dermatol Venereol. 2015;29(9):1750-1757. DOI: 10.1111/jdv.12993. PMID: 25682915.
Uchiyama M, Harada K, Tobita R, Irisawa R, Tsuboi R. Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: A case series. J Am Acad Dermatol. 2021;85(5):1185-1193. DOI: 10.1016/j.jaad.2020.03.092. PMID: 32272176.
Dervout C, Chiappa AM, Fleuret C, Plantin P, Acquitter M. Alopécie cicatricielle à type de folliculite décalvante induite par l’erlotinib [Erlotinib-induced scarring alopecia with a folliculitis decalvans-like presentation]. Ann Dermatol Venereol. 2020;147(12):848-852. DOI: 10.1016/j.annder.2020.08.043. PMID: 33097309.
Hoekzema R, Drillenburg P. Folliculitis decalvans associated with erlotinib. Clin Exp Dermatol. 2010;35(8):916-918. DOI: 10.1111/j.1365-2230.2010.03852.x. PMID: 20456379.
Published
Issue
Section
License
Copyright (c) 2023 Miriam Anna Carpanese, Michela Starace, Bianca Maria Piraccini, Matilde Iorizzo, Zoe Apalla

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

